1. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment
- Author
-
Hofstra, J.M., Loves, S., Wageningen, B. van, Ruinemans-Koerts, J., Jansen, I., and Boer, H. de
- Subjects
Renal disorders [UMCN 5.4] ,body regions - Abstract
Item does not contain fulltext BACKGROUND: Obesity can be associated with biochemical evidence of isolated hypogonadotropic hypogonadism (IHH) in men. Prevalence and severity of IHH in obese men are not exactly known. OBJECTIVE: To assess the prevalence of IHH in obese men. DESIGN AND SUBJECTS: Cross-sectional study of 160 obese men, BMI >30 kg/m2, who applied for medical or surgical treatment of obesity in a general teaching hospital. Main outcome measures: Total and calculated free testosterone (TT and FT) in relation to body mass index (BMI). RESULTS: Mean age of the study population was 43.3 +/- 0.8 years (mean +/- SEM), BMI ranged from 30.0 to 65.7 kg/m2. TT and FT levels were inversely related to BMI (-0.48, p
- Published
- 2008